Lobbying

National Down Syndrome Congress's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q2 2023; the issues it reports most are Budget/Appropriations and Education.

National Down Syndrome Congress

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q2 2023
The first quarter a report named it

Lobbying by quarter

No lobbying spend in this period.

National Down Syndrome Congress lobbying by quarter
National Down Syndrome Congress lobbying by quarter
QuarterAmountReports
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Budget and appropriations$0 · 13 reports
  • Education$0 · 13 reports
  • Health issues$0 · 13 reports
  • Labor, antitrust and workplace$0 · 13 reports
  • Medicare and Medicaid$0 · 13 reports
  • Insurance$0 · 9 reports
  • Taxation$0 · 7 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports
  • Labor, Dept of (DOL)7 reports
  • White House Office1 reports

Firms it paid

Firm
In-houseNational Down Syndrome Congress$013 quarters

Former officials lobbying for it

Former position
ANTHONY CHAPMAN BRYANT iiPolicy and Advocacy AssociateQ4 2023

Lobbying reports

Filed by
07/20for Q2In-houseUnder $5,000
04/15for Q1In-houseUnder $5,000
01/19for Q4 2025In-houseUnder $5,000
25/11/03for Q3 2025In-houseUnder $5,000
25/07/21for Q2 2025In-houseUnder $5,000
25/04/28for Q1 2025In-houseUnder $5,000
25/01/22for Q4 2024In-houseUnder $5,000
24/12/11for Q3 2024In-houseUnder $5,000
24/10/21for Q3 2024In-houseUnder $5,000
24/09/26for Q1 2024In-houseUnder $5,000
24/07/22for Q2 2024In-houseUnder $5,000
24/05/02for Q2 2023In-houseUnder $5,000
24/04/30for Q1 2024In-houseUnder $5,000
24/01/19for Q4 2023In-houseUnder $5,000
23/10/20for Q3 2023In-houseUnder $5,000
23/08/05for Q2 2023In-houseUnder $5,000
23/05/11for Q2 2023In-houseUnder $5,000